Literature DB >> 30471754

Teledermatology in China: History, Current Status, and the Next Step.

Yajie Zheng1, Yan Lin2, Yong Cui3.   

Abstract

Telemedicine, as defined by the World Health Organization, is the use of communication technologies in healthcare for the exchange of medical information for diagnosis, treatment, prevention, research, evaluation, and education over a distance (World Health Organization, 1998). Since the 1990s, with the rapid development of modern communication technology, telemedicine, which can be used by almost all medical specialties, has likely entered its "golden age," However, some of the more visual medical specialties may be more suitable, such as teleradiology, telepathology, and teledermatology.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2018        PMID: 30471754     DOI: 10.1016/j.jisp.2018.09.003

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  4 in total

1.  Web-based study on Chinese dermatologists' attitudes towards artificial intelligence.

Authors:  Changbing Shen; Chengxu Li; Feng Xu; Ziyi Wang; Xue Shen; Jing Gao; Randy Ko; Yan Jing; Xiaofeng Tang; Ruixing Yu; Junhu Guo; Feng Xu; Rusong Meng; Yong Cui
Journal:  Ann Transl Med       Date:  2020-06

2.  When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice.

Authors:  Gang Chen; Yangzhong Zhou; Jinghua Xia; Jia Yao; Ke Zheng; Yan Qin; Xuemei Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study.

Authors:  Zhanglei Mu; Xiaojing Liu; Kun Li; Jianzhong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-08-27

4.  Implementation and Application of Telemedicine in China: Cross-Sectional Study.

Authors:  Fangfang Cui; Qianqian Ma; Xianying He; Yunkai Zhai; Jie Zhao; Baozhan Chen; Dongxu Sun; Jinming Shi; Mingbo Cao; Zhenbo Wang
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-23       Impact factor: 4.773

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.